Title story in the journal Cancers highlights discovery by Kancera scientists

Kancera AB (Nasdaq First North Premier Growth Market: KAN) has previously announced groundbreaking research results for Kancera’s fractalkine blockers, which could pave the way for new treatments of ovarian cancer. The journal Cancers (https://www.mdpi.com/journal/cancers) has chosen to top their...

Read More